ArticleNature communications2026

EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge.

Christopher F Bassil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.